EUCTR2005-000393-47-ITActive, not recruitingNot Applicable
Effect of Cannabis Based Medicine Extract Sativex on brain function as assessed by fMRI and neurophysiologic evaluation in patients with Multiple Sclerosis a double blind, randomised, placebo-controlled, crossover study.
AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA0 sitesStarted: March 5, 2007Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 1
Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain ActivationCannabisDependenceCannabis AbusePharmacokineticsfMRINCT01037608National Institute on Drug Abuse (NIDA)108
Unknown
Phase 4
Efficacy of Cannabis Oil for Alleviating Side Effects of Breast Cancer Chemotherapy: A Randomized Double-blinded Controlled TrialMicrobiotaBreast cancer patients with high or low emitik conditions who are willing to apply the CBC2Cannabis oilMetabolitesBreast cancerTCTR20220809001Thai Traditional Medical Knowledge Fund90
Not yet recruiting
Phase 3
Investigating the effects of a cannabis-based medication on sleep problems in chronic paiChronic PainAnaesthesiology - Pain managementNeurological - Other neurological disordersInsomniaACTRN12623000870651IVERSITY OF AUCKLAND20
Completed
Phase 3
Anti inflammatory effects of Cannabis sativa L. seed oil in hemodialysis patientsEnd Stage Renal Disease (Hemodialysis).Chronic kidney disease, stage 5IRCT2017031522637N3Vice chancellor for research, Kerman University of Medical Sciences130
Completed
Not Applicable
Cannabis fOr Management of Pain: Assessment of Safety Study: COMPASSISRCTN19449752McGill University Health Centre (Canada)1,400
